Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 137419-24-0 | MDL No. : | MFCD03160565 |
Formula : | C18H23NO2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | HRTHPQOIDCOMHE-UHFFFAOYSA-N |
M.W : | 285.38 | Pubchem ID : | 3653579 |
Synonyms : |
|
Num. heavy atoms : | 21 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.5 |
Num. rotatable bonds : | 3 |
Num. H-bond acceptors : | 2.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 88.94 |
TPSA : | 29.54 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | Yes |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -5.28 cm/s |
Log Po/w (iLOGP) : | 3.43 |
Log Po/w (XLOGP3) : | 3.89 |
Log Po/w (WLOGP) : | 3.49 |
Log Po/w (MLOGP) : | 3.43 |
Log Po/w (SILICOS-IT) : | 3.03 |
Consensus Log Po/w : | 3.45 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -4.07 |
Solubility : | 0.0241 mg/ml ; 0.0000844 mol/l |
Class : | Moderately soluble |
Log S (Ali) : | -4.21 |
Solubility : | 0.0177 mg/ml ; 0.0000619 mol/l |
Class : | Moderately soluble |
Log S (SILICOS-IT) : | -4.09 |
Solubility : | 0.0233 mg/ml ; 0.0000817 mol/l |
Class : | Moderately soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 3.48 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P280-P305+P351+P338-P304+P340 | UN#: | N/A |
Hazard Statements: | H302 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
78.7% | Stage #1: With 9-bora-bicyclo[3.3.1]nonane In tetrahydrofuran at 20℃; for 24 h; Inert atmosphere Stage #2: With pyridinium chlorochromate In dichloromethane at 0℃; Reflux |
Under an argon atmosphere, a solution of t-butyl spiro(indene-1,4'-piperidine)-1'-carboxylate (514 mg, 1.80 mmol) in tetrahydrofuran (5 mL) was added with a solution of 9-borabicyclo[3.3.1]nonane in tetrahydrofuran (0.5 M, 10.5 mL) at room temperature, and the resultant was stirred at the same temperature for 24 hours. The reaction solution was concentrated in vacuo, dissolved into dichloromethane (8 mL), and added with pyridinium chlorochromate (2.30 g, 10.7 mmol) at 0° C. The resultant was stirred for 2 hours by heating under reflux. The reaction solution was filtered using celite, and concentrated in vacuo. The resultant residue was purified using silica-gel chromatography (hexane:ethylacetate=4:1), and t-butyl 3-oxo-2,3-dihydrospriro(indene-1,4'-piperidine-1'-carboxylate (23.5 mg, 78.7percent) was obtained as a colorless oil.1H-NMR (400 MHz, CDCl3) δ; 1.46-1.57 (m, 2H), 1.50 (s, 9H), 1.96-2.01 (m, 2H), 2.64 (s, 2H), 2.80-2.89 (m, 2H), 4.20-4.26 (br, 2H), 7.42 (t, J=7.3 Hz, 1H), 7.49 (d, J=7.3 Hz, 1H), 7.65 (t, J=7.3 Hz, 1H), 7.74 (d, J=7.3 Hz, 1H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
In ethyl acetate; | 1'-(t-Butyloxycarbonyl)spiro(indene-1,4'-piperidine) (16 g, 56 mmole) in ethyl acetate (250 ml) was stirred in an ice bath and saturated with HCl(g) for 30 minutes. The mixture was evaporated to dryness. Ethyl acetate was added and removed in vacuo three times, and the residue was triturated with diethyl ether and filtered to provide spiro(1H-indene-1,4'-piperidine) hydrochloride. | |
In ethyl acetate; | 3 1'-(t-Butyloxycarbonyl)spiro(indene-1,4'-piperidine) (16 g, 56 mmole) in ethyl acetate (250 ml) was stirred in an ice bath and saturated with HCl(g) for 30 min. The mixture was evaporated to dryness. Ethyl acetate was added and removed in vacuo three times, and the residue was triturated with diethyl ether and filtered to provide spiro(1H-indene-1,4'-piperidine) hydrochloride. The free base was obtained by slurrying the hydrochloride in aqueous sodium bicarbonate solution and extracting with CH2 Cl2. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
65% | With lithium hexamethyldisilazane In tetrahydrofuran at 0℃; | |
58% | With lithium hexamethyldisilazane; hydrazine In tetrahydrofuran at 2℃; for 2.5h; Cooling with ice; | 86 Tert-butyl spiro[indene-1,4'-piperidine]-1'-carboxylate(Compound 86A) Add the compound hydrazine (3.5g, 30mmol) to a 250ml eggplant-shaped bottleAnd dry tetrahydrofuran (5ml),Under ice bath conditions, lithium bis(trimethylsilyl)amide (60 ml, 1 M in tetrahydrofuran) was slowly added to a 250 ml eggplant-shaped flask.After stirring for 30 minutes,Addition of N,N-bis(2-chloroethyl)carbamic acid tert-butyl ester40 ml of a solution of (6.8 g, 281 mmol) in tetrahydrofuran.After stirring for 30 minutes in an ice bath, it was returned to room temperature and stirred for 2 h.Then column chromatography gave compound 86A(5 g, 58% yield). |
57% | Stage #1: 1-indene With lithium hexamethyldisilazane In tetrahydrofuran at 20℃; for 1h; Stage #2: N-(2,2'-bischloro)diethyl-N-(1,1-dimethylethoxy)carbonyl amine In tetrahydrofuran at 0 - 20℃; for 2.5h; | 1 To a solution of indene 1 (34.6g, 298 mmol) in dry THF (40 rnL) maintained under a nitrogen blanket was added lithium bis(trimethylsilyl) amide (596 mL of a 1.0 M solution in THF; 596 mmol) over 30 min. The mixture was stirred in the cold for 30 min and then transferred by a canula to a solution of N, N-bis (2-chloroethyl)-tert-butyl carbamate 2 (68g, 281 mmol) in dry THF (40 mL), and stirred in an ice bath. The mixture was stirred for 2 hours in the cold and for 30 min at ambient temperature under nitrogen and then evaporated in vacuo to a foam. Methylene chloride was added and the resulting reaction mixture was chromatographed on silica (1:20 ethyl acetate-hexane) . The product fractions were evaporated to dryness in vacuo to give (49g, 57%) of l'-(tert- butyloxycarbonyl)spiro(indene-l,4'-piperidine ) 3 as a white solid, mp 128 oC. IR (KBr) 3435, 2964, 2856, 1679, 1427, 1165 cm-1; IH NMR (CDC13, 400 MHz) δ 1.26 (br d, J = 13.4 Hz, 2H), 1.43 (s, 9H), 1.93 (dt, J = 12.9, 4.5 Hz, 2H), 3.04 (dt, J = 13.0, 2.7 Hz, 2H), 4.11 (br d, J = 13.5 Hz, 2H), 6.71 (d, J = 5.7 Hz, IH), 6.77 (d, J = 5.7 Hz, IH), 7.11-7.19 (m, 2H), 7.23-7.26 (m, 2H); 13C NMR (CDC13, 100 MHz) δ 28.47, 33.39, 42.48, 52.03, 79.56, 121.45, 121.65, 125.30, 126.98, 130.25, 140.32, 142.73, 151.65, 155.01; GC MS (EI) m/z 285. |
50.2% | Stage #1: 1-indene With lithium hexamethyldisilazane In tetrahydrofuran; hexane at 0℃; for 1h; Inert atmosphere; Stage #2: N-(2,2'-bischloro)diethyl-N-(1,1-dimethylethoxy)carbonyl amine In tetrahydrofuran; hexane at 0℃; for 2h; | 1.1 Under an argon atmosphere, a solution of indene (2.00 g, 18.0 mmol) in tetrahydrofuran (15 mL) was added with a solution of lithium hexamethyldisilazide in hexane (1.0 M, 36 mL) at 0° C. The resultant was stirred at the same temperature for 1 hour. Then, a solution of N-t-butyloxycarbonylbis(2-chloroethyl)amine (4.24 g, 18.0 mmol) in tetrahydrofuran (10 mL) was added thereto, and the mixture was further stirred at the same temperature for 2 hours. The reaction solution was concentrated in vacuo, and the resultant residue was purified using silica-gel chromatography (diethylether) and t-butyl spiro(indene-1,4'-piperidine)-1'-carboxylate (2.58 g, 50.2%) was obtained as a yellow amorphous solid.1H-NMR (400 MHz, CDCl3) δ; 1.33 (d, J=12.7 Hz, 2H), 1.51 (s, 9H), 1.96-2.07 (m, 2H), 3.07-3.17 (m, 2H), 4.10-4.21 (m, 2H), 6.78 (d, J=5.7 Hz, 1H), 6.84 (d, J=5.7 Hz, 1H), 7.20-7.34 (m, 4H). |
47% | Stage #1: 1-indene With lithium hexamethyldisilazane In tetrahydrofuran at 10℃; for 0.5h; Inert atmosphere; Stage #2: N-(2,2'-bischloro)diethyl-N-(1,1-dimethylethoxy)carbonyl amine In tetrahydrofuran at 10 - 20℃; Inert atmosphere; | tert-butylspiro[indene-1,4'-piperidine]-1'-carboxylate (7) To a well stirred solution of 1H-indene (2g, 17.22 mmol) dissolvedin THF (40 ml), lithium bis(trimethylsilyl)amide (36.2 ml, 36.16 mmol) wasadded slowly under N2 atmosphere. The temperature was maintainedbelow 10C during the course of addition. After stirring for additional 30 minbelow 10C, a solution of 6 (3.75 g,15.50 mmol) dissolved in THF (40 mL) was added drop-wise to the above mixture.The temperature was again maintained below 10oC during the course ofaddition. The reaction mixture was warmed to room temperature and stirring wascontinued overnight. Completion of the reaction was monitored by LCMS. After completion of the reaction, the crudemixture was diluted with ethyl acetate (100mL) and the organic layer waswashed with water, dried over Na2SO4 and evaporated underreduced pressure to give a crude product. Purification of the crude product byflash chromatography through pre-loaded silica gel columns usingdichloromethane-hexane gradient to give 2.3g of tert-butyl spiro[indene-1,4'-piperidine]-1'-carboxylate (7), in 47% yield. ESMS calcd. 285.4;Found: 230.1 (M- tBu). |
36% | Stage #1: 1-indene With lithium hexamethyldisilazane In tetrahydrofuran at -50℃; for 1h; Stage #2: N-(2,2'-bischloro)diethyl-N-(1,1-dimethylethoxy)carbonyl amine In tetrahydrofuran at -50℃; for 1h; | 1.a Step a: Amixture of Compound 1H-indene (11.62g, 0.lOmol) and LiHMDS (220mL, lmol/L in THF) in THF(l2OmL) was stirred at -50°C for 1 hour. Tert-butyl bis(2-chloroethyl)carbamate (24.21g, 0.lOmol) was added to the reaction mixture and stirred at -50°C for lhr. The reaction was quenched with brine (300mL). The organic extracts were dried with anhydrous Na2504, and concentrated under reduced pressure in vacuo. The residue was purified by column chromatography to afford Compound tert-butyl spiro [indene- 1 ,4’-piperidine] -1 ‘-carboxylate as a yellow solid (10.36g, 36%). MS: 286 (M+H). |
36% | Stage #1: 1-indene With lithium hexamethyldisilazane In tetrahydrofuran at -50℃; for 1h; Stage #2: N-(2,2'-bischloro)diethyl-N-(1,1-dimethylethoxy)carbonyl amine In tetrahydrofuran at -50℃; for 1h; | 1.a Step a: Compound 1H- indene (11.62g, 0.10mol)A mixture of LiHMDS (220 mL, 1 mol/L in THF) The mixture in THF (120 mL) was stirred at -50 °C for 1 h.tert-Butyl bis(2-chloroethyl)carbamate (24.21 g, 0.10 mol) was added to the reaction mixture and stirred at -50 ° C for 1 h.Quenched with brine (300 mL). Dry the organic phase with anhydrous Na2SO4.Filter and concentrate under reduced pressure. The residue was purified by silica gel chromatography.The compound spiro[-1,4'-piperidine]-1'-carboxylic acid tert-butyl ester (10.36 g, 36%) was obtained as a yellow solid. |
28.6% | Stage #1: 1-indene With lithium hexamethyldisilazane In tetrahydrofuran; hexane at 0℃; for 1h; Inert atmosphere; Stage #2: N-(2,2'-bischloro)diethyl-N-(1,1-dimethylethoxy)carbonyl amine In tetrahydrofuran; hexane at 0℃; for 2h; | 5.1 Step 1 tert-Butyl spiro[indene- 1 ,4’-piperidine] -1 ‘-carboxylate A solution of lithium hexamethyldisilazide (8.61 mmol) in hexane was added to a solution of indene (4.3 mmol) in THF (5 mL) at 0 °C under an argon atmosphere. The resultant was stirred at the same temperature for 1 h. Then a solution of N-tbutyloxycarbonylbis(2-chloroethyl)amine (4.3 mmol) in THF (2 mL) was added and the reaction mixture was further stirred at the same temperature for 2 h. After completion of reaction, the reaction mixture was poured in ice-cold water, extracted with diethyl ether, dried over Na2504, concentrated and purified by flash column chromatography (silica gel column, 0-40% DCM/petroleum ether). Yield: 28.6 % 1H NMR (CDC13, 300 MHz): 7.341 (m, 4H),6.877 (d, J= 5.7, 1H), 6.817 (d, J= 5.7, 1H), 4.189 (bs, 2H), 3.179 (t, J= 12.3, 2H), 2.064 (m, 2H), 1.527 (s, 9H), 1.371 (d, J= 13.2, 2H); MS: (mlz) 308.3 (M+Na). |
26.4% | With Etamon; sodium hydride In N,N-dimethyl-formamide at -20 - 20℃; for 3h; | 68 The indene (2 g, 17.2 mmol) was dissolved in 150 mL of dimethylformamide, then tetraethylammonium bromide (636 mg,1.72 mmol, 0.1 eq.) was added, and sodium hydride (1.5 g) was added portionwise at -20 °C. 37.8 mmol, 2.2 eq.), then 68a(4.5 g, 18.92 mmol, 1.1 eq.) was added dropwise, and the mixture was reacted at room temperature for 3 h after completion of the dropwise addition.After the reaction is completed, the ice water is slowly added dropwise, and thepH is adjusted to neutralitywith hydrochloric acid, and thendiluted with water, extracted three times with ethyl acetate, washed three times with saturated brine, and the organic phase is combined, dried andevaporated todryness.(1.3 g of, as a white solid), yield% 26.4. |
With lithium hexamethyldisilazane 1.) THF, 30 min, 2.) THF, a) 30 min, b) RT, 20 min; Yield given. Multistep reaction; | ||
With lithium hexamethyldisilazane 1.) THF, 0 deg C, 30 min, 2.) THF, 0 deg C, 2 h; Yield given. Multistep reaction; | ||
With sodium hydride In N,N-dimethyl-formamide at 0 - 20℃; | 1.1a.2 1H-Indene (U6g, lO.Ommol), bis-(2-chloro-ettιyl)-carbamic acid tert-butyl ester (2.41g, lO.Ommol), and catalytic tetrabutylammonium iodide were combined in DMF and cooled to O0C. Sodium hydride (60% in mineral oil; 0.44Og, 11.Ommol) was added, and the mixture was warmed to room temperature and stirred overnight. The reaction was quenched with H2O and extracted with MTBE, and the combined organic layers were washed with H2O, dried over MgSO4, filtered, and concentrated. The residue was purified by silica gel chromatography to give the desired product (2.17g). | |
352.4 mg | Stage #1: 1-indene With lithium hexamethyldisilazane In tetrahydrofuran at 0℃; for 1h; Stage #2: N-(2,2'-bischloro)diethyl-N-(1,1-dimethylethoxy)carbonyl amine In tetrahydrofuran at 0 - 20℃; for 3h; | 40.1 Step 1 First, indene (3.42 g) was dissolved in tetrahydrofuran (8 mL), the mixture was cooled to 0 C, and lithium bis(trimethylsilyl) amide (1.0 M tetrahydrofuran solution) (60 mL) was added dropwise thereto. After 1 hour, a tetrahydrofuran solution (13 mL) of N-tert-butyloxycarbonylbis(2-chloroethyl)amine (6.44 g) was added dropwise to the reaction solution, and the mixture was stirred at 0 C for 30 minutes, and then was stirred at room temperature for 2 hours 30 minutes. Water was added to the reaction solution, followed by four times of extraction with chloroform. The organic layer was washed with saturated brine, then was dried with anhydrous sodium sulfate, and was concentrated under reduced pressure. The obtained residue was purified by silica gel column chromatography (ethyl acetate/n-hexane = 0/100 to 15/85) to obtain 1’-tert-butyloxycarbonylspiro[indene-1,4’-piperidine] (3.74 g). 1H-NMR (270MHz, CDCl3) δ: 1.33 (br.d, J=12.9Hz, 2H), 1.51 (s, 9H), 1.90-2.11 (m, 2H), 3.12 (br.t , J=12.2Hz, 2H), 4.05-4.31 (m, 2H), 6.76-6.89 (m, 2H), 7.14-7.39 (m, 4 H). MS (ESI) m/z:230 [M- (tert-Bu) +H]+. |
Stage #1: 1-indene With 1,1,1,3,3,3-hexamethyl-disilazane In tetrahydrofuran at 0℃; for 1h; Inert atmosphere; Stage #2: N-(2,2'-bischloro)diethyl-N-(1,1-dimethylethoxy)carbonyl amine In tetrahydrofuran for 2h; Inert atmosphere; | Preparation of Compound S13 Under the protection of argon, the Compound 13-1 was dissolved in THF, and HMDLi (2 eq) was added dropwise to the solution at 0°C, then reacted at 0°C for 1 hour. Then tert-butyl N, N-bis(2-chloroethyl)carbamate (1eq) was diluted with THF, and added dropwise to the reaction flask and the reaction was continued for 2 hours. The raw materials were completely reacted. The reaction was quenched with saturated ammonium chloride, and the reaction solution was concentrated, dissolved with ethyl acetate, and water was added for extraction. The organic layer was washed with saturated brine, dried over anhydrous sodium sulfate, dried by rotary evaporation, then Compound 13-2 was obtained by silica gel column chromatography (PE : EA = 40 : 1). | |
Stage #1: 1-indene With 1,1,1,3,3,3-hexamethyl-disilazane In tetrahydrofuran at 0℃; for 1h; Inert atmosphere; Stage #2: N-(2,2'-bischloro)diethyl-N-(1,1-dimethylethoxy)carbonyl amine In tetrahydrofuran for 2h; Inert atmosphere; | Preparation of Compound S13 Under the protection of argon, the Compound 13-1 was dissolved in THF, and HMDLi (2 eq) was added dropwise to the solution at 0°C, then reacted at 0°C for 1 hour. Then tert-butyl N, N-bis(2-chloroethyl)carbamate (1eq) was diluted with THF, and added dropwise to the reaction flask and the reaction was continued for 2 hours. The raw materials were completely reacted. The reaction was quenched with saturated ammonium chloride, and the reaction solution was concentrated, dissolved with ethyl acetate, and water was added for extraction. The organic layer was washed with saturated brine, dried over anhydrous sodium sulfate, dried by rotary evaporation, then Compound 13-2 was obtained by silica gel column chromatography (PE : EA = 40 : 1). | |
Stage #1: 1-indene With lithium hexamethyldisilazane In tetrahydrofuran at 0℃; for 1h; Inert atmosphere; Stage #2: N-(2,2'-bischloro)diethyl-N-(1,1-dimethylethoxy)carbonyl amine In tetrahydrofuran for 2h; | Preparation of Compound S13 Under the protection of argon, the Compound 13-1 was dissolved in THF, and HMDLi (2 eq) was added dropwise to the solution at 0°C, then reacted at 0°C for 1 hour. Then tert-butyl N, N-bis(2-chloroethyl)carbamate (1eq) was diluted with THF, and added dropwise to the reaction flask and the reaction was continued for 2 hours. The raw materials were completely reacted. The reaction was quenched with saturated ammonium chloride, and the reaction solution was concentrated, dissolved with ethyl acetate, and water was added for extraction. The organic layer was washed with saturated brine, dried over anhydrous sodium sulfate, dried by rotary evaporation, then Compound 13-2 was obtained by silica gel column chromatography (PE : EA = 40 : 1). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
78.7% | Under an argon atmosphere, a solution of t-butyl spiro(indene-1,4'-piperidine)-1'-carboxylate (514 mg, 1.80 mmol) in tetrahydrofuran (5 mL) was added with a solution of 9-borabicyclo[3.3.1]nonane in tetrahydrofuran (0.5 M, 10.5 mL) at room temperature, and the resultant was stirred at the same temperature for 24 hours. The reaction solution was concentrated in vacuo, dissolved into dichloromethane (8 mL), and added with pyridinium chlorochromate (2.30 g, 10.7 mmol) at 0 C. The resultant was stirred for 2 hours by heating under reflux. The reaction solution was filtered using celite, and concentrated in vacuo. The resultant residue was purified using silica-gel chromatography (hexane:ethylacetate=4:1), and t-butyl 3-oxo-2,3-dihydrospriro(indene-1,4'-piperidine-1'-carboxylate (23.5 mg, 78.7%) was obtained as a colorless oil.1H-NMR (400 MHz, CDCl3) delta; 1.46-1.57 (m, 2H), 1.50 (s, 9H), 1.96-2.01 (m, 2H), 2.64 (s, 2H), 2.80-2.89 (m, 2H), 4.20-4.26 (br, 2H), 7.42 (t, J=7.3 Hz, 1H), 7.49 (d, J=7.3 Hz, 1H), 7.65 (t, J=7.3 Hz, 1H), 7.74 (d, J=7.3 Hz, 1H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With sodium hydroxide; 9-bora-[3.3.1]-bicyclononane dimer; dihydrogen peroxide | ||
Stage #1: tert-butyl spiro[indene-1,4’-piperidine]-1‘-carboxylate With 9-bora-bicyclo[3.3.1]nonane In tetrahydrofuran at 0 - 70℃; for 8h; Stage #2: With sodium hydroxide; dihydrogen peroxide In tetrahydrofuran; lithium hydroxide monohydrate | 1.1a.3 To lH-l '-(tert-butoxycarbonyl)-sρiro[mdene-l,4'-piperidine] (1.35g, 4.8mmol) in THF (3OmL) at O0C was added 9-borabicyclo[3.3.1]nonane (0.5M in THF; 19.OmL, 9.5mmol). The reaction was heated to 700C in a sealed tube for 8 hours, and then carefully quenched with aqueous IN NaOH (9.5mL, 9.5mmol) and aqueous hydrogen peroxide (29%; 1.14mL, 9.5mmol). The mixture was cooled to room temperature and extracted with EtOAc, and the combined organic layers were dried over MgSO4, filtered, and concentrated, and the crude material was used directly in the next step. | |
352.4 mg | Stage #1: tert-butyl spiro[indene-1,4’-piperidine]-1‘-carboxylate With 9-bora-bicyclo[3.3.1]nonane In tetrahydrofuran at 70℃; for 17h; Sealed tube; Stage #2: With dihydrogen peroxide; sodium hydroxide In tetrahydrofuran; lithium hydroxide monohydrate at 70℃; | 40.2 <Step 2> The 1'-tert-butyloxycarbonylspiro[indene-1,4'-piperidine] (380 mg) was dissolved in tetrahydrofuran (8 mL), 9-borabicyclo[3,3,1-nonane (0.5 M tetrahydrofuran solution) (5.3 mL) was added thereto, and the mixture was stirred at 70ºC for 17 hours in a sealed tube. A 1 M sodium hydroxide aqueous solution (2.7 mL) and 30% aqueous hydrogen peroxide (0.272 mL) were added to the reaction solution, the mixture was then brought back to room temperature. After that, water was added to the reaction solution, followed by four times of extraction with ethyl acetate. The organic layer was washed with saturated brine, then was dried with anhydrous sodium sulfate, and was concentrated under reduced pressure. The obtained residue was purified by silica gel column chromatography (ethyl acetate/n-hexane = 0/100 to 50/50) to obtain 1'-tert-butyloxycarbonyl-3-hydroxy-2,3-spiro[indene-1,4'-pi peridine] (352.4 mg). 1H-NMR (270MHz, CDCl3) δ:1.34-1.85 (m,3H), 1.49 (s, 9H), 1.87-2.02 (m , 2H), 2.53 (dd, J=13.5, 7.3Hz,1H), 2.95 (br.t, J=12.7Hz, 2H), 4.04-4 .24 (m, 2H), 5.23-5.35 (m, 1H), 7.17-7.24 (m, 1H), 7.28-7.38 (m, 2H), 7 .38-7.44 (m, 1H). MS (ESI) m/z:248 [M-(tert-Bu)+H]+. |
With 9-bora-bicyclo[3.3.1]nonane In tetrahydrofuran at 70℃; for 3h; | Preparation of Compound S13 The Compound 13-2 was dissolved in THF, and 9-BBN (3 eq) was added to the solution. After reacting at 70°C for 3 hours, the raw materials were completely reacted. The reaction solution was cooled to 0°C, and 3 M NaOH solution (1.2 eq) and 30% hydrogen peroxide solution (1.2 eq) were added to the reaction solution, and reacted at room temperature for 1 hour. Then the reaction solution was concentrated, diluted with ethyl acetate, and water was added for extraction. The organic layer was washed with saturated brine, dried over anhydrous sodium sulfate, and dried by rotary evaporation to obtain Compound 13-3. | |
With 9-bora-bicyclo[3.3.1]nonane In tetrahydrofuran at 70℃; for 3h; | Preparation of Compound S13 The Compound 13-2 was dissolved in THF, and 9-BBN (3 eq) was added to the solution. After reacting at 70°C for 3 hours, the raw materials were completely reacted. The reaction solution was cooled to 0°C, and 3 M NaOH solution (1.2 eq) and 30% hydrogen peroxide solution (1.2 eq) were added to the reaction solution, and reacted at room temperature for 1 hour. Then the reaction solution was concentrated, diluted with ethyl acetate, and water was added for extraction. The organic layer was washed with saturated brine, dried over anhydrous sodium sulfate, and dried by rotary evaporation to obtain Compound 13-3. | |
Stage #1: tert-butyl spiro[indene-1,4’-piperidine]-1‘-carboxylate With 9-bora-bicyclo[3.3.1]nonane In tetrahydrofuran at 70℃; for 3h; Stage #2: With dihydrogen peroxide; sodium hydroxide In tetrahydrofuran; lithium hydroxide monohydrate at 0 - 20℃; for 1h; | Preparation of Compound S13 The Compound 13-2 was dissolved in THF, and 9-BBN (3 eq) was added to the solution. After reacting at 70°C for 3 hours, the raw materials were completely reacted. The reaction solution was cooled to 0°C, and 3 M NaOH solution (1.2 eq) and 30% hydrogen peroxide solution (1.2 eq) were added to the reaction solution, and reacted at room temperature for 1 hour. Then the reaction solution was concentrated, diluted with ethyl acetate, and water was added for extraction. The organic layer was washed with saturated brine, dried over anhydrous sodium sulfate, and dried by rotary evaporation to obtain Compound 13-3. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With sodium hydroxide; borane; dihydrogen peroxide In tetrahydrofuran | ||
Stage #1: 1'-(tert-butyloxycarbonyl)spiro<1H-indene-1,4'-piperidine> With dimethylsulfide borane complex In tetrahydrofuran at 0℃; for 3h; Stage #2: With dihydrogen peroxide; sodium hydroxide In tetrahydrofuran at 0℃; for 1h; | 1.b Step b: The compound spiro[-1,4'-piperidine]-1'-carboxylic acid tert-butyl ester (117.02 g, 0.41 mol)A solution of the borane dimethyl sulfide complex (10 mol/L, 220 mL) in THF (800 mL) was stirred at 0 ° C for 3 h.NaOH (2 mol/L, 1.2 L) and H 2 O 2 (300 mL) were added and stirred at 0 ° C for 1 h.The organic phase was collected, dried over anhydrous Na2SO4, filtered and evaporated.Obtaining 2-hydroxy-2,3-dihydrospiro[-1,4'-piperidine]-1'-carboxylic acid tert-butyl ester andTert-butyl 3-hydroxy-2,3-dihydrospiro[-1,4'-piperidine]-1'-carboxylate,Yellow oil (130.33 g, crude). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
95% | With pyridine; dihydrogen peroxide; methyltrioxorhenium(VII) In dichloromethane for 5h; Ambient temperature; |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 2 steps 1: 95 percent / 30 percent aq. H2O2, methyltrioxorhenium(VII), pyridine / CH2Cl2 / 5 h / Ambient temperature 2: 86 percent / ammonium formate / 5 percent Pd/C / dioxane / 2 h / 80 °C |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 4 steps 1: 95 percent / 30 percent aq. H2O2, methyltrioxorhenium(VII), pyridine / CH2Cl2 / 5 h / Ambient temperature 2: 86 percent / ammonium formate / 5 percent Pd/C / dioxane / 2 h / 80 °C 3: 86 percent / pyridinium chlorochromate, 4 A molecular sieves / CH2Cl2 / 0.5 h / Ambient temperature 4: 61 percent / BH3*THF, (R)-2-methyl-CBS-oxazaborolidine / tetrahydrofuran; toluene / 1 h / Ambient temperature | ||
Multi-step reaction with 2 steps 1: (S,S)-(+)-N,N'-bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediaminomanganese(III) chloride, 4-phenylpyridine N-oxide / CH2Cl2 / 0.17 h 2: 86 percent / ammonium formate / 5 percent Pd/C / dioxane / 80 °C |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 5 steps 1: 95 percent / 30 percent aq. H2O2, methyltrioxorhenium(VII), pyridine / CH2Cl2 / 5 h / Ambient temperature 2: 86 percent / ammonium formate / 5 percent Pd/C / dioxane / 2 h / 80 °C 3: 86 percent / pyridinium chlorochromate, 4 A molecular sieves / CH2Cl2 / 0.5 h / Ambient temperature 4: 61 percent / BH3*THF, (R)-2-methyl-CBS-oxazaborolidine / tetrahydrofuran; toluene / 1 h / Ambient temperature 5: 92 percent / 4 N HCl / ethanol; dioxane / 5 h / Ambient temperature | ||
Multi-step reaction with 3 steps 1: (S,S)-(+)-N,N'-bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediaminomanganese(III) chloride, 4-phenylpyridine N-oxide / CH2Cl2 / 0.17 h 2: 86 percent / ammonium formate / 5 percent Pd/C / dioxane / 80 °C 3: 92 percent / 4 N HCl / ethanol; dioxane / 5 h / Ambient temperature |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 2 steps 1: 1.) 9-NBN, 2.) PCC 2: TFA / CH2Cl2 |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 2 steps 1: BH3, NaOH, H2O2 / tetrahydrofuran 2: TFA / CH2Cl2 |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 2 steps 1: OsO4, NMO 2: TFA / CH2Cl2 |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 4 steps 1: 1.) 9-NBN, 2.) PCC 2: TFA / CH2Cl2 3: EDC, HOBT, NMM 4: TFA / CH2Cl2 |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 4 steps 1: 1.) 9-NBN, 2.) PCC 2: TFA / CH2Cl2 3: EDC, HOBT, NMM 4: TFA / CH2Cl2 |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 4 steps 1: 1.) 9-NBN, 2.) PCC 2: TFA / CH2Cl2 3: EDC, HOBT, NMM 4: TFA / CH2Cl2 |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 4 steps 1: BH3, NaOH, H2O2 / tetrahydrofuran 2: TFA / CH2Cl2 3: EDC, HOBT, NMM 4: TFA / CH2Cl2 |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 4 steps 1: OsO4, NMO 2: TFA / CH2Cl2 3: EDC, HOBT, NMM 4: TFA / CH2Cl2 |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 3 steps 1: 1.) 9-NBN, 2.) PCC 2: TFA / CH2Cl2 3: EDC, HOBT, NMM |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 3 steps 1: BH3, NaOH, H2O2 / tetrahydrofuran 2: TFA / CH2Cl2 3: EDC, HOBT, NMM |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 3 steps 1: 1.) 9-NBN, 2.) PCC 2: TFA / CH2Cl2 3: EDC, HOBT, NMM |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 3 steps 1: BH3, NaOH, H2O2 / tetrahydrofuran 2: TFA / CH2Cl2 3: EDC, HOBT, NMM |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 3 steps 1: OsO4, NMO 2: TFA / CH2Cl2 3: EDC, HOBT, NMM |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 3 steps 1: OsO4, NMO 2: TFA / CH2Cl2 3: EDC, HOBT, NMM |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 3 steps 1: BH3, NaOH, H2O2 / tetrahydrofuran 2: TFA / CH2Cl2 3: EDC, HOBT, NMM |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 3 steps 1: 1.) 9-NBN, 2.) PCC 2: TFA / CH2Cl2 3: EDC, HOBT, NMM |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 3 steps 1: OsO4, NMO 2: TFA / CH2Cl2 3: EDC, HOBT, NMM |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 2 steps 1: 88 percent / triethylamine / CH2Cl2 2: 1.) lithium bis(trimethylsilyl)amide / 1.) THF, 0 deg C, 30 min, 2.) THF, 0 deg C, 2 h | ||
Multi-step reaction with 2 steps 1: triethylamine / CH2Cl2 / 1 h / Ambient temperature 2: 1.) lithium bis(trimethylsilyl)amide / 1.) THF, 30 min, 2.) THF, a) 30 min, b) RT, 20 min | ||
Multi-step reaction with 2 steps 1.1: sodium hydroxide / dichloromethane / 6 h / 20 °C 2.1: lithium hexamethyldisilazane / tetrahydrofuran / 0.5 h / 10 °C / Inert atmosphere 2.2: 10 - 20 °C / Inert atmosphere |
Multi-step reaction with 2 steps 1: triethylamine / dichloromethane / Cooling with ice 2: tetraethylammonium bromide; sodium hydride / N,N-dimethyl-formamide / 3 h / -20 - 20 °C |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 2 steps 1: 99 percent / HCl(g) / ethyl acetate / 0.5 h / 0 °C 2: 43 percent / H2 / Pd/C / ethanol / 1 h / 2585.7 Torr |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 2 steps 1: HCl (g) / ethyl acetate / 0.5 h / 12 °C 2: triethylamine / CH2Cl2 / 1 h / Ambient temperature |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 2 steps 1: HCl (g) / ethyl acetate / 0.5 h / 12 °C 2: triethylamine / CH2Cl2 / 1 h / Ambient temperature |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 2 steps 1: HCl (g) / ethyl acetate / 0.5 h / 12 °C 2: triethylamine / CH2Cl2 / 1 h / Ambient temperature |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 2 steps 1: HCl (g) / ethyl acetate / 0.5 h / 12 °C 2: triethylamine / CH2Cl2 / 1 h / Ambient temperature |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 2 steps 1: HCl (g) / ethyl acetate / 0.5 h / 12 °C 2: triethylamine / CH2Cl2 / 1 h / Ambient temperature |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 2 steps 1: HCl (g) / ethyl acetate / 0.5 h / 12 °C 2: triethylamine / CH2Cl2 / 1 h / Ambient temperature |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 2 steps 1: HCl (g) / ethyl acetate / 0.5 h / 12 °C 2: triethylamine / CH2Cl2 / 1 h / Ambient temperature |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 2 steps 1: HCl (g) / ethyl acetate / 0.5 h / 12 °C 2: triethylamine / CH2Cl2 / 1 h / Ambient temperature |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 2 steps 1: HCl (g) / ethyl acetate / 0.5 h / 12 °C 2: triethylamine / CH2Cl2 / 1 h / Ambient temperature |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 2 steps 1: HCl (g) / ethyl acetate / 0.5 h / 12 °C 2: triethylamine / CH2Cl2 / 1 h / Ambient temperature |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 2 steps 1: HCl (g) / ethyl acetate / 0.5 h / 12 °C 2: triethylamine / CH2Cl2 / 1 h / Ambient temperature |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 2 steps 1: HCl (g) / ethyl acetate / 0.5 h / 12 °C 2: triethylamine / CH2Cl2 / 1 h / Ambient temperature |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 2 steps 1: HCl (g) / ethyl acetate / 0.5 h / 12 °C 2: triethylamine / CH2Cl2 / 1 h / Ambient temperature |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 2 steps 1: HCl (g) / ethyl acetate / 0.5 h / 12 °C 2: triethylamine / CH2Cl2 / 1 h / Ambient temperature |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 2 steps 1: HCl (g) / ethyl acetate / 0.5 h / 12 °C 2: triethylamine / CH2Cl2 / 1 h / Ambient temperature |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 2 steps 1: HCl (g) / ethyl acetate / 0.5 h / 12 °C 2: triethylamine / CH2Cl2 / 1 h / Ambient temperature |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 2 steps 1: HCl (g) / ethyl acetate / 0.5 h / 12 °C 2: triethylamine / CH2Cl2 / 1 h / Ambient temperature |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 2 steps 1: HCl (g) / ethyl acetate / 0.5 h / 12 °C 2: triethylamine / CH2Cl2 / 1 h / Ambient temperature |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 2 steps 1: HCl (g) / ethyl acetate / 0.5 h / 12 °C 2: triethylamine / CH2Cl2 / 1 h / Ambient temperature |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 2 steps 1: HCl (g) / ethyl acetate / 0.5 h / 12 °C 2: triethylamine / CH2Cl2 / 1 h / Ambient temperature |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 2 steps 1: HCl (g) / ethyl acetate / 0.5 h / 12 °C 2: triethylamine / CH2Cl2 / 1 h / Ambient temperature |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 2 steps 1: HCl (g) / ethyl acetate / 0.5 h / 12 °C 2: triethylamine / CH2Cl2 / 1 h / Ambient temperature |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 2 steps 1: HCl (g) / ethyl acetate / 0.5 h / 12 °C 2: triethylamine / CH2Cl2 / 1 h / Ambient temperature |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 2 steps 1: HCl (g) / ethyl acetate / 0.5 h / 12 °C 2: triethylamine / CH2Cl2 / 1 h / Ambient temperature |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 2 steps 1: HCl (g) / ethyl acetate / 0.5 h / 12 °C 2: triethylamine / CH2Cl2 / 1 h / Ambient temperature |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 2 steps 1: HCl (g) / ethyl acetate / 0.5 h / 12 °C 2: triethylamine / CH2Cl2 / 1 h / Ambient temperature |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 2 steps 1: HCl (g) / ethyl acetate / 0.5 h / 12 °C 2: triethylamine / CH2Cl2 / 1 h / Ambient temperature |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 2 steps 1: HCl (g) / ethyl acetate / 0.5 h / 12 °C 2: triethylamine / CH2Cl2 / 1 h / Ambient temperature |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 2 steps 1: HCl (g) / ethyl acetate / 0.5 h / 12 °C 2: triethylamine / CH2Cl2 / 1 h / Ambient temperature |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 2 steps 1: HCl (g) / ethyl acetate / 0.5 h / 12 °C 2: triethylamine / CH2Cl2 / 1 h / Ambient temperature |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 2 steps 1: HCl (g) / ethyl acetate / 0.5 h / 12 °C 2: triethylamine / CH2Cl2 / 1 h / Ambient temperature |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 2 steps 1: HCl (g) / ethyl acetate / 0.5 h / 12 °C 2: triethylamine / CH2Cl2 / 1 h / Ambient temperature |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 4 steps 1: HCl (g) / ethyl acetate / 0.5 h / 12 °C 2: triethylamine / CH2Cl2 / 1 h / Ambient temperature 3: 1.) lithium hexamethyldisilazide / 1.) THF, -78 deg C, 15 min, 2.) THF, -78 deg C, 10 min 4: LiOH*H2O / tetrahydrofuran / 18 h / Ambient temperature |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 4 steps 1: HCl (g) / ethyl acetate / 0.5 h / 12 °C 2: triethylamine / CH2Cl2 / 1 h / Ambient temperature 3: 1.) lithium N-isopropyl-N-cyclohexylamine / 1.) THF, -78 deg C, 15 min, 2.) THF, -78 deg C, 10 min 4: LiOH*H2O / tetrahydrofuran / 18 h / Ambient temperature |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 4 steps 1: HCl (g) / ethyl acetate / 0.5 h / 12 °C 2: triethylamine / CH2Cl2 / 1 h / Ambient temperature 3: 1.) lithium hexamethyldisilazide / 1.) THF, -78 deg C, 15 min, 2.) THF, -78 deg C, 10 min 4: LiO*H2O / 18 h / Ambient temperature |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 3 steps 1: HCl (g) / ethyl acetate / 0.5 h / 12 °C 2: triethylamine / CH2Cl2 / 1 h / Ambient temperature 3: 1.) lithium hexamethyldisilazide / 1.) THF, -78 deg C, 15 min, 2.) THF, -78 deg C, 10 min |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 3 steps 1: HCl (g) / ethyl acetate / 0.5 h / 12 °C 2: triethylamine / CH2Cl2 / 1 h / Ambient temperature 3: 1.) lithium N-isopropyl-N-cyclohexylamine / 1.) THF, -78 deg C, 15 min, 2.) THF, -78 deg C, 10 min |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 2 steps 1: HCl (g) / ethyl acetate / 0.5 h / 12 °C 2: triethylamine / CH2Cl2 / 1 h / Ambient temperature |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 2 steps 1: HCl (g) / ethyl acetate / 0.5 h / 12 °C 2: triethylamine / CH2Cl2 / 1 h / Ambient temperature |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 3 steps 1: HCl (g) / ethyl acetate / 0.5 h / 12 °C 2: triethylamine / CH2Cl2 / 1 h / Ambient temperature 3: 60 percent / LiAlH4 / tetrahydrofuran / Ambient temperature |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 3 steps 1: HCl (g) / ethyl acetate / 0.5 h / 12 °C 2: triethylamine / CH2Cl2 / 1 h / Ambient temperature 3: 35 percent / LiAlH4 / tetrahydrofuran / Ambient temperature |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 3 steps 1: HCl (g) / ethyl acetate / 0.5 h / 12 °C 2: triethylamine / CH2Cl2 / 1 h / Ambient temperature 3: LiAlH4 / tetrahydrofuran / Ambient temperature |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 3 steps 1: HCl (g) / ethyl acetate / 0.5 h / 12 °C 2: triethylamine / CH2Cl2 / 1 h / Ambient temperature 3: LiAlH4 / tetrahydrofuran / Ambient temperature |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 2 steps 1: HCl (g) / ethyl acetate / 0.5 h / 12 °C 2: triethylamine / CH2Cl2 / 1 h / Ambient temperature |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 2 steps 1: HCl (g) / ethyl acetate / 0.5 h / 12 °C 2: triethylamine / CH2Cl2 / 1 h / Ambient temperature |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
58% | In tetrahydrofuran | 1.2 Step 2: Step 2: 1'-(tert-Butyloxycarbonyl)spiro [indene-1,4'-piperidine] To a solution of indene (5.1 ml, 0.04 mol) in dry tetrahydrofuran (15 ml), cooled in an ice bath and maintained under an atmosphere of nitrogen, was added lithium bis (trimethylsilyl) amide (82 ml of a 1.0M solution in tetrahydrofuran, 0.08 mol), over 15 minutes. The mixture was stirred in the cold for 30 minutes, then added dropwise to a solution of N-tert-butyloxycarbonylbis (2-chloroethyl)amine (9.9 g, 0.04 mol) in tetrahydrofuran (200 ml), at 0° C. The mixture was stirred for 2 hours at this temperature, then allowed to warm to ambient temperature and stirred for a further 30 minutes. The solvent was removed in vacuo to leave a dark oil, which was chromatographed using 5:1 petrol:ether as the eluant, to give 1'-(tert-butyloxycarbonyl)spiro[indene-1,4'-piperidine] (7.1 g, 58%) as a pale yellow solid. N.M.R. (CDCl3)δ 1.28 (2H, d, J=12 Hz), 1.50 (9H, s), 2.00 (2H, t of d, J=12 and 4 Hz), 3.13 (2H, t of d, J=12 and 2 Hz), 4.20 (2H, m), 6.79 (1H, d, J=6 Hz), 6.84 (1H, d, J=6 Hz), 7.30 (4H, m). |
In tetrahydrofuran | R.1 N-t-Butoxycarbonyl-spiro(1H-indene-1,4'-piperidine) Referential Example 1 N-t-Butoxycarbonyl-spiro(1H-indene-1,4'-piperidine) In 60 ml of anhydrous tetrahydrofuran, 11.6 g (0.10 mole) of indene were dissolved, followed by the gradual dropwise addition of 200 ml (0.20 mole) of lithium bistrimethylsilylamide (a 1.0M tetrahydrofuran solution) for one hour under ice cooling. After stirring the reaction mixture for 30 minutes, 50 ml of a tetrahydrofuran solution of 24.2 g (0.10 mole) of N-t-butoxycarbonyl-bis(2-chloroethyl)amine were added dropwise to the reaction mixture for 20 minutes. The resulting mixture was further stirred for 2 hours under ice cooling. The reaction mixture was distilled under reduced pressure. The residue was purified by silica gel column chromatography (eluent; n-hexane:ethyl acetate=97:3), whereby 21.3 g (89%) of the title compound were obtained as white crystals. Nuclear magnetic resonance spectrum (400 MHz, CDCl3) δ ppm: 7.21-7.41 (4H,m), 6.85 (1H,d,J=5.7 Hz), 6.79 (1H,d,J=5.7 Hz), 4.11-4.28 (2H,m), 3.07-3.23 (2H,m), 2.01 (2H,dt,J=12.8,4.5 Hz), 1.51 (9H,s), 1.47-1.50(2H,m) Infrared absorption spectrum νmax cm-1 (KBr): 2965, 1680, 1425, 1365, 1245, 1165 Mass spectrometric analysis (EI) m/z: 285 (M+) |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With hydrogenchloride; In ethanol; palladium; ethyl acetate; | Step 3: Spiro[indane-1,4'-piperidine]hydrochloride A solution of 1'-(tert-butyloxycarbonyl)spiro[indene-1,4'-piperidine] (3.0 g, 0.011 mol) in ethyl acetate (150 ml) was stirred at 0 C., and treated with hydrogen chloride for 30 minutes. The mixture was then evaporated to dryness, ethyl acetate (100 ml) was added, then removed in vacuo three times. The residue was stirred with anhydrous ether (200 ml), and the solid filtered off, to give <strong>[137730-67-7]spiro[indene-1,4'-piperidine] hydrochloride</strong> (2.3 g, 99%) as a pale yellow solid. The product was not purified further. A solution of spiro[indene-1,4'-piperidine]hydrochloride (1.9 g, 8.6 mmol) in ethanol (50 ml) was hydrogenated at 50 p.s.i. for 1 hour, in the present of 10% palladium on carbon (0.3 g, 16% (w/w)). The catalyst was filtered off, and the ethanol removed in vacuo. The remaining solid was recrystallized from 4:1 ethyl acetate:ethanol to give spiro[indane-1,4'-piperidine] hydrochloride (814 mg, 43%) as a white crystalline solid. N.M.R. (D2 O)delta 1.79 (2H, d, J=14 Hz), 2.06 (2H, t of d, J=14 and 4 Hz), 2.14 (2H, t, J=7 Hz), 2.98 (2H, t, j=7 Hz), 3.25 (2H, t of d, J=14 and 2 Hz), 3.48 (2H, m), 7.33 (4H, m) |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
326 mg (47%) | With pyridinium chlorochromate In tetrahydrofuran; dichloromethane | 4.A 1'-(t-butyloxycarbonyl)-3,4-dihydro-3-oxospiro[1H-indene-1,4'-piperidine] Step A 1'-(t-butyloxycarbonyl)-3,4-dihydro-3-oxospiro[1H-indene-1,4'-piperidine] To a solution of 661 mg (2.31 mmol) of 1'-(t-butyloxycarbonyl)spiro[1H-indene-1,4'-piperidine][prepared by the method of Chambers, et al, J. Med. Chem., 1992, 35, 2036] in 5.0 ml of THF was added 5.8 ml (1.0M THF, 2.9 mmol) of 9-BBN. The reaction mixture was heated at 70° C. until TLC analysis indicated that the starting material was consumed. The solution was concentrated and the residue was dissolved in dichloromethane. The solution was cooled to 0° C. and 4.1 g (19.2 mmol) of PCC was added slowly over 15 minutes. The reaction mixture was warmed to room temperature and then to reflux for 30 minutes. The solution was then diluted with ether and filtered through a pad of a mixture of celite and florisil. Purification by flash chromotgraphy (silica gel, hexane/ethyl acetate, 4:1) gave 326 mg (47%) of the title compound. 1 H NMR (200 MHz, CDCl3): 7.75-7.60 (m, 2H), 7.50-7.44 (m, 2H), 4.30-4.15 (m, 2H), 2.85 (dt, 2H), 2.63 (s, 2H), 1.98 (dt, 2H), 1.53-1.40 (m, 2H), 1.49 (s, 9H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
In tetrahydrofuran; hexane; dichloromethane; lithium hexamethyldisilazane | A Endo-(1S)-1'(((2-amino-7,7-dimethylbicyclo(2.2.1)-hept-1-yl)-methyl)-sulfonyl)spiro(1H-indan-1,4'-piperidine) STR9 To a solution of indene (10.3 g, 89 mmole) in dry tetrahydrofuran (THF, 18 ml) cooled in an ice bath and maintained under a nitrogen blanket was added lithium bis(trimethylsilyl)amide (Aldrich, 177 ml of a 1.0M solution in THF; 177 mmole) over 15 minutes. The mixture was stirred in the cold for 30 minutes, then added over 15 minutes to a solution of N,N-bis(2-chloroethyl)-t-butylcarbamate (21.2 g, 88 mmole) stirred in an ice bath. The mixture was stirred for 2 hours in the cold and for 30 minutes at ambient temperature under nitrogen, then evaporated in vacuo to a foam. CH2 Cl2 was added and the resulting mixture poured onto a silica gel column packed with 40% hexane in CH2 Cl2. The column was eluted with 40% hexane in CH2 Cl2 followed by CH2 CL2, and the product fractions were evaporated to dryness in vacuo to provide 1'-(t-butyloxycarbonyl)-spiro(indene-1,4'-piperidine). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
In tetrahydrofuran; hexane; dichloromethane; lithium hexamethyldisilazane | 1.2 Step 2 Step 2 To a solution of indene (10.3 g, 89 mmole) in dry tetrahydrofuran (THF, 18 ml) cooled in an ice bath and maintained under a nitrogen blanket was added lithium bis(trimethylsilyl)amide (177 ml of a 1.0M solution in THF; 177 mmole) over 15 min. The mixture was stirred in the cold for 30 min, then added over 15 min to a solution of N,N-bis(2-chloroethyl)-t-butylcarbamate (21.2 g, 88 mmole) stirred in an ice bath. The mixture was stirred for 2 hrs in the cold and for 30 min at ambient temperature under nitrogen, then evaporated in vacuo to a foam. CH2 Cl2 was added and the resulting mixture poured onto a silica gel column packed with 40% hexane in CH2 Cl2. The column was eluted with 40% hexane in CH2 Cl2 followed by CH2 Cl2, and the product fractions were evaporated to dryness in vacuo to provide 1'-(t-butyloxycarbonyl)-spiro(indene-1,4'-piperidine). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With hydrogen;palladium 10% on activated carbon; In ethanol; for 2h; | N-Boc spiro[lH-indene-l,4'-piperidine] (700 mg, 2.45 mmol) is added to ethanol (50 ml) in a Parr-shaker and hydrogenated over Pd/C (10%) for 2 h. The resulting reaction mixture is filtered through Celite and concentrated to dryness. The crude product is used without further purification for the next step. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Stage #1: 1'-(tert-butyloxycarbonyl)spiro<1H-indene-1,4'-piperidine> With hydrogen bromide In dichloromethane for 12h; Stage #2: With sodium hydrogencarbonate In dichloromethane; water | 1 To a stirring solution of 3 (20g, 70.2 mmol) in dry methylene chloride ( 450 mL) was passed gaseous HBr for 12 hours. The reaction mixture was carefully neutralized with saturated sodium bicarbonate solution (150 mL). The aqueous part was separated out and the organic part back extracted with saturated sodium bicarbonate (2x50 mL). To the aqueous extract and the combined washings was added 14.7 g of solid sodium bicarbonate, 400 mL of methylene chloride followed by 15.4 g (70.2 mmol) of di- tert-butyl pyrocarbonate. The reaction mixture was stirred at ambient temperature for 3 hours. The organic layer was separated out and the aqueous part was washed successively with methylene chloride (3x 50 mL), dried and concentrated in vacuo to provide a foaming liquid which was chromatographed on silica (3:7 ethyl acetate-hexane followed by 1:1 ethyl acetate-hexane) to provide l'-(tert-butyloxycarbonyl)spiro(indan-l-ol, 4'-piperidine) 5 (21g , 99% ) as a viscous liquid. IR (film) 3401, 2925, 2347, 1691,1669, 1425, 1365, 1166 cm-1; IH NMR (CDC13 , 400 MHz) δ 1.37 (dd, J = 13.4, 2.0 Hz, IH), 1.49 (s, 9H), 1.62 (dd, J = 13.2, 1.9 Hz, IH), 1.73 (dt, J = 13.0 , 4.4 Hz, 1 H), 1.87-1.96 (m, 2H), 2.49 (dd, J = 13.4, 7.1 Hz, IH), 2.62 (br s, IH), 2.92 (tt, J = 11.7, 2.9 Hz, 2H), 4.09 (d, J = 11 Hz, 2H), 5.25 (t, J = 12.2 Hz, IH), 7.18 (d, J = 7.4 Hz, IH), 7.25-7.33 (m, 2H), 7.41 (d, J = 7.09 Hz, IH); 13C NMR (CDC13, 100 MHz) δ 28.39, 37.04, 38.04, 41.21, 41.37, 44.70, 44.94, 73.98, 79.52, 122.59, 124.43, 127.48, 128.64, 143.96, 150.10, 154.90; MS (EI) m/z 303. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
98% | With trifluoroacetic acid; In dichloromethane;Cooling with ice; | Trifluoroacetic acid (0.4 mL) was added to an ice-cold solution of tert-butylspiro[indene-1,4’-piperidine]-l’-carboxylate (compound of step 1, 1.226 mmol) in DCM (5mL) and the reaction mixture was stirred for 2-4 h. The solvent is evaporated to obtain thetitle compound. Yield: 98%; 1H NMR (CDC13, 300 MHz): 8.875 (bs, 1H), 8.624 (bs, 1H),7.383 (m, 2H), 7.294 (m, 2H), 7.135, (d, J= 5.7, 1H), 6.883 (d, J= 5.4, 1H), 3.408 (m, 2H),3.305 (m, 2H), 2.266 (t, J= 13.2, 2H), 1.402 (t, J= 15.3, 2H); MS: (mlz) 298.6 (M-H). |
93% | With trifluoroacetic acid; In dichloromethane; | Compound 86A (4 g, 14 mmol) was added to trifluoroacetic acid (10 ml) and dichloromethane (10 ml).Concentrated to give compound 86B(2.4 g, 93% yield). |
93% | With trifluoroacetic acid; In dichloromethane; at 20℃; | Intermediate 68b (1.3 g, 4.56 mmol) was dissolved in 10 mL of dichloromethane.Add trifluoroacetic acid (0.68 mL, 9·12 mmol, 2 equivalents),The reaction was carried out overnight at room temperature. Evaporated to get 68 (790 mg, purple solid),The yield was 93%. |
77.1% | A solution of t-butyl spiro(indene-1,4'-piperidine)-1'-carboxylate (380 mg, 1.33 mmol) in dichloromethane (1 mL) was added with trifluoroacetic acid (0. 5 mL), and stirred at room temperature for 10 minutes. The reaction solution was concentrated in vacuo, and the resultant residue was diluted into chloroform. The resultant was washed with a saturated aqueous solution of sodium hydrogen carbonate, concentrated in vacuo, and spiro(indene-1,4'-piperidine) (190 mg, 77.1%) was obtained as a white amorphous solid.1H-NMR (400 MHz, CDCl3) δ; 1.35 (d, J=13.0 Hz, 2H), 2.05-2.13 (m, 2H), 2.98-3.05 (m, 2H), 3.21-3.27 (m, 2H), 6.76 (d, J=5.9 Hz, 1H), 6.89 (d, J=5.9 Hz, 1H), 7.19-7.26 (m, 2H), 7.32 (d, J=6.6 Hz, 1H), 7.39 (d, J=6.6 Hz, 1H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
99% | In dichloromethane at 10℃; for 22h; | 141.2 Synthesis of 1‘-(2,2,2-trifluoroacetoxy)spiro[indene-1,4’-piperidin]-1‘-ium Trifluoroacetic acid (6.07 mL, 79 mmol) was added to solution of tert-butyl spiro[indene-1,4’-piperidine]-l’-carboxylate (3 g, 10.51 mmol) in DCM (15 mL) at 10 °C. The reaction mixture was stirred for 22 h. After completion of reaction the solvent was removed. On removal of solvent from a reaction mass the residue was azeotroped with toulene and suspended with petroleum ether (40 mL) and decanted. The residue was dried to obtain the title compound (3.1 g). Yield: 99%; 1H NMR (300 MHz, DMSO-d6): 1.59 (d, J = 12.0 Hz, 2H), 2.42 (t, J = 12.0 Hz. 2H), 3.29 (q, J = 9.0 Hz, 2H), 3.62 (d, J = 2H), 6.79 (d, J =1H), 6.89 (d, J = 3.0 Hz, 1H), 7.28-7.50 (m, 3H), 9.29 (s, 1H), 9.72 (s, 1H); MS (mlz) 186.3 (free base). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
100% | With bromine In tetrahydrofuran at 5℃; for 2h; | tert-butyl2,3-dibromo-2,3-dihydrospiro[indene-1,4'-piperidine]-1'-carboxylate (8) To a well stirred solution of tert-butylspiro[indene-1,4'-piperidine]-1'-carboxylate (0.5 g, 1.75 mmol) 7 in THF (40 ml), bromine (0.117 ml,2.28 mmol) dissolved in THF (10mL) was added over a period of 10 min. Thetemperature was maintained below 5oC during addition and thestirring was continued for another 2h at that temperature. Completion of thereaction was monitored by LCMS. After completion of the reaction, the crudemixture was poured onto NaHCO3 solution and the residue wasextracted into EtOAc (100mL). The organic layer was washed with water, driedover Na2SO4 and evaporated under reduced pressure to give0.8g of pure tert-butyl2,3-dibromo-2,3-dihydrospiro[indene-1,4'-piperidine]-1'-carboxylate 8 inquantitative yield. The product was used in next step without furtherpurification. ESMS calcd. 445.1; Found: 389.8 (M- tBu,). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
A mixture of tert-butyl2-hydroxy-2 ,3 -dihydrospiro [indene- 1 ,4?-piperidine] -1 ?-carboxylate and tert-butyl3-hydroxy-2 ,3 -dihydrospiro [indene- 1 ,4?-piperidine] -1 ?-carboxylate (130. 02g, 0 .43mo1) andDess-Martin periodinane (364.76g, 0.86mo1) in DCM (2L) was stirred at 25C for 12 hours. The reaction mixture was filtered and the filtrate was washed by saturated sodium bicarbonate solution (1L) and brine (1L). The organic extracts were dried over anhydrous Na2504 and concentrated under reduced pressure in vacuo. The residue was purified by column chromatography to afford Compound tert-butyl 3 -oxo-2 ,3 -dihydrospiro [indene- 1 ,4?-piperidine] -1 ?-carboxylate as a whitesolid (41.75g, 34%, 2 steps). MS: 302 (M+H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Stage #1: dimethylsulfide borane complex; 1'-(tert-butyloxycarbonyl)spiro<1H-indene-1,4'-piperidine> In tetrahydrofuran at 0℃; for 3h; Stage #2: With dihydrogen peroxide; sodium hydroxide In tetrahydrofuran at 0℃; for 1h; | 1.b Step b : A mixture of Compound tert-butyl spiro [indene- 1 ,4’-piperidine] -1 ‘-carboxylate(117.02g, 0.4lmol) and borane-methyl sulfide complex (lOmol/L, 220mL) in THF (800mL) wasstirred at 0°Cfor 3 hours. NaOH (2mol/L, 1 .2L) and H202 (300mL) was added and stirred at 0°C for 1 hour. The organic extracts were collected, dried over anhydrous Na2504 and concentrated under reduced pressure in vacuo to afford the mixture of tert-butyl2-hydroxy-2,3 -dihydrospiro [indene- 1 ,4’-piperidine] -1 ‘-carboxylate and tert-butyl3-hydroxy-2 ,3 -dihydrospiro [indene- 1 ,4’-piperidine] -1 ‘-carboxylate as a yellow oil (130.33 g, crude). MS: 304 (M+H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
The compound spiro[-1,4'-piperidine]-1'-carboxylic acid tert-butyl ester (117.02 g, 0.41 mol)A solution of the borane dimethyl sulfide complex (10 mol/L, 220 mL) in THF (800 mL) was stirred at 0 C for 3 h.NaOH (2 mol/L, 1.2 L) and H 2 O 2 (300 mL) were added and stirred at 0 C for 1 h.The organic phase was collected, dried over anhydrous Na2SO4, filtered and evaporated.Obtaining 2-hydroxy-2,3-dihydrospiro[-1,4'-piperidine]-1'-carboxylic acid tert-butyl ester andTert-butyl 3-hydroxy-2,3-dihydrospiro[-1,4'-piperidine]-1'-carboxylate,Yellow oil (130.33 g, crude). Step c:2. 2-Hydroxy-2,3-dihydrospiro[-1,4'-piperidine]-1'-carboxylic acid tert-butyl ester and.tert-Butyl 3-hydroxy-2,3-dihydrospiro[-1,4'-piperidine]-1'-carboxylate (130.02 g, 0.43 mol), Dess-Martin Oxidant (364.76 g, 0.86 mol) The mixture with DCM (2 L) was stirred at 25 C for 12 h.Filter the reaction solution and use saturated sodium bicarbonate solution(1L) and brine (1L),Dry with anhydrous Na2SO4,Filter and concentrate under reduced pressure.The residue was purified by column chromatography to give a white solid.tert-Butyl 3-oxo-2,3-dihydrospiro[-1,4'-piperidine]-1'-carboxylate (41.75 g, 34%, yield in two steps). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Stage #1: 1'-(tert-butyloxycarbonyl)spiro<1H-indene-1,4'-piperidine> With dimethylsulfide borane complex In tetrahydrofuran at 0℃; for 3h; Stage #2: With dihydrogen peroxide; sodium hydroxide In tetrahydrofuran at 0℃; for 1h; Stage #3: (R)-2-methylpropane-2-sulfinamide Further stages; | 1.b; 1.c; 1.d Step b: The compound spiro[-1,4'-piperidine]-1'-carboxylic acid tert-butyl ester (117.02 g, 0.41 mol)A solution of the borane dimethyl sulfide complex (10 mol/L, 220 mL) in THF (800 mL) was stirred at 0 ° C for 3 h.NaOH (2 mol/L, 1.2 L) and H 2 O 2 (300 mL) were added and stirred at 0 ° C for 1 h.The organic phase was collected, dried over anhydrous Na2SO4, filtered and evaporated.Obtaining 2-hydroxy-2,3-dihydrospiro[-1,4'-piperidine]-1'-carboxylic acid tert-butyl ester andTert-butyl 3-hydroxy-2,3-dihydrospiro[-1,4'-piperidine]-1'-carboxylate,Yellow oil (130.33 g, crude). Step c:2. 2-Hydroxy-2,3-dihydrospiro[-1,4'-piperidine]-1'-carboxylic acid tert-butyl ester and.tert-Butyl 3-hydroxy-2,3-dihydrospiro[-1,4'-piperidine]-1'-carboxylate (130.02 g, 0.43 mol), Dess-Martin Oxidant (364.76 g, 0.86 mol) The mixture with DCM (2 L) was stirred at 25 ° C for 12 h.Filter the reaction solution and use saturated sodium bicarbonate solution(1L) and brine (1L),Dry with anhydrous Na2SO4,Filter and concentrate under reduced pressure.The residue was purified by column chromatography to give a white solid.tert-Butyl 3-oxo-2,3-dihydrospiro[-1,4'-piperidine]-1'-carboxylate (41.75 g, 34%, yield in two steps). Step d:To the compound 3-oxo-2,3-dihydrospiro[-1,4'-piperidine]-1'-carboxylic acid tert-butyl ester (41.01 g, 0.14 mol)To a solution of ethyl titanate (80 mL) was added R-(+)-tert-butylsulfinamide (49.46 g, 0.41 mol).The system was stirred at 85 ° C for 2 h.EA (0.5 L) and water (0.5 L) were added to the reaction system.The reaction system was filtered and the organic phase was collected. The aqueous phase was extracted with EA (200 mL×2).The combined organic phases were washed with brine (500 mL).Dry with anhydrous Na2SO4,Filter and concentrate under reduced pressure to give the compound(R,E)-2-((tert-butylsulfinyl)imino)-2,3-dihydrospiro[-1,4'-piperidine]-1'-carboxylic acid tert-butyl ester (132.05 g, crude).Not used directly in the next step without purification. . |
Tags: 137419-24-0 synthesis path| 137419-24-0 SDS| 137419-24-0 COA| 137419-24-0 purity| 137419-24-0 application| 137419-24-0 NMR| 137419-24-0 COA| 137419-24-0 structure
[ 1160247-60-8 ]
tert-Butyl 5-methylspiro[indene-1,4'-piperidine]-1'-carboxylate
Similarity: 1.00
[ 1160247-62-0 ]
tert-Butyl 6-methylspiro[indene-1,4'-piperidine]-1'-carboxylate
Similarity: 1.00
[ 400769-49-5 ]
(1R,3'R)-tert-Butyl 3'-methylspiro[indene-1,4'-piperidine]-1'-carboxylate
Similarity: 0.99
[ 158628-80-9 ]
tert-Butyl 6-bromospiro[indene-1,4'-piperidine]-1'-carboxylate
Similarity: 0.92
[ 1160247-59-5 ]
tert-Butyl 6-fluorospiro[indene-1,4'-piperidine]-1'-carboxylate
Similarity: 0.92
[ 1160247-60-8 ]
tert-Butyl 5-methylspiro[indene-1,4'-piperidine]-1'-carboxylate
Similarity: 1.00
[ 1160247-62-0 ]
tert-Butyl 6-methylspiro[indene-1,4'-piperidine]-1'-carboxylate
Similarity: 1.00
[ 400769-49-5 ]
(1R,3'R)-tert-Butyl 3'-methylspiro[indene-1,4'-piperidine]-1'-carboxylate
Similarity: 0.99
[ 158628-80-9 ]
tert-Butyl 6-bromospiro[indene-1,4'-piperidine]-1'-carboxylate
Similarity: 0.92
[ 1160247-59-5 ]
tert-Butyl 6-fluorospiro[indene-1,4'-piperidine]-1'-carboxylate
Similarity: 0.92
[ 1160247-60-8 ]
tert-Butyl 5-methylspiro[indene-1,4'-piperidine]-1'-carboxylate
Similarity: 1.00
[ 1160247-62-0 ]
tert-Butyl 6-methylspiro[indene-1,4'-piperidine]-1'-carboxylate
Similarity: 1.00
[ 400769-49-5 ]
(1R,3'R)-tert-Butyl 3'-methylspiro[indene-1,4'-piperidine]-1'-carboxylate
Similarity: 0.99
[ 158628-80-9 ]
tert-Butyl 6-bromospiro[indene-1,4'-piperidine]-1'-carboxylate
Similarity: 0.92
[ 1160247-59-5 ]
tert-Butyl 6-fluorospiro[indene-1,4'-piperidine]-1'-carboxylate
Similarity: 0.92
Precautionary Statements-General | |
Code | Phrase |
P101 | If medical advice is needed,have product container or label at hand. |
P102 | Keep out of reach of children. |
P103 | Read label before use |
Prevention | |
Code | Phrase |
P201 | Obtain special instructions before use. |
P202 | Do not handle until all safety precautions have been read and understood. |
P210 | Keep away from heat/sparks/open flames/hot surfaces. - No smoking. |
P211 | Do not spray on an open flame or other ignition source. |
P220 | Keep/Store away from clothing/combustible materials. |
P221 | Take any precaution to avoid mixing with combustibles |
P222 | Do not allow contact with air. |
P223 | Keep away from any possible contact with water, because of violent reaction and possible flash fire. |
P230 | Keep wetted |
P231 | Handle under inert gas. |
P232 | Protect from moisture. |
P233 | Keep container tightly closed. |
P234 | Keep only in original container. |
P235 | Keep cool |
P240 | Ground/bond container and receiving equipment. |
P241 | Use explosion-proof electrical/ventilating/lighting/equipment. |
P242 | Use only non-sparking tools. |
P243 | Take precautionary measures against static discharge. |
P244 | Keep reduction valves free from grease and oil. |
P250 | Do not subject to grinding/shock/friction. |
P251 | Pressurized container: Do not pierce or burn, even after use. |
P260 | Do not breathe dust/fume/gas/mist/vapours/spray. |
P261 | Avoid breathing dust/fume/gas/mist/vapours/spray. |
P262 | Do not get in eyes, on skin, or on clothing. |
P263 | Avoid contact during pregnancy/while nursing. |
P264 | Wash hands thoroughly after handling. |
P265 | Wash skin thouroughly after handling. |
P270 | Do not eat, drink or smoke when using this product. |
P271 | Use only outdoors or in a well-ventilated area. |
P272 | Contaminated work clothing should not be allowed out of the workplace. |
P273 | Avoid release to the environment. |
P280 | Wear protective gloves/protective clothing/eye protection/face protection. |
P281 | Use personal protective equipment as required. |
P282 | Wear cold insulating gloves/face shield/eye protection. |
P283 | Wear fire/flame resistant/retardant clothing. |
P284 | Wear respiratory protection. |
P285 | In case of inadequate ventilation wear respiratory protection. |
P231 + P232 | Handle under inert gas. Protect from moisture. |
P235 + P410 | Keep cool. Protect from sunlight. |
Response | |
Code | Phrase |
P301 | IF SWALLOWED: |
P304 | IF INHALED: |
P305 | IF IN EYES: |
P306 | IF ON CLOTHING: |
P307 | IF exposed: |
P308 | IF exposed or concerned: |
P309 | IF exposed or if you feel unwell: |
P310 | Immediately call a POISON CENTER or doctor/physician. |
P311 | Call a POISON CENTER or doctor/physician. |
P312 | Call a POISON CENTER or doctor/physician if you feel unwell. |
P313 | Get medical advice/attention. |
P314 | Get medical advice/attention if you feel unwell. |
P315 | Get immediate medical advice/attention. |
P320 | |
P302 + P352 | IF ON SKIN: wash with plenty of soap and water. |
P321 | |
P322 | |
P330 | Rinse mouth. |
P331 | Do NOT induce vomiting. |
P332 | IF SKIN irritation occurs: |
P333 | If skin irritation or rash occurs: |
P334 | Immerse in cool water/wrap n wet bandages. |
P335 | Brush off loose particles from skin. |
P336 | Thaw frosted parts with lukewarm water. Do not rub affected area. |
P337 | If eye irritation persists: |
P338 | Remove contact lenses, if present and easy to do. Continue rinsing. |
P340 | Remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P341 | If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P342 | If experiencing respiratory symptoms: |
P350 | Gently wash with plenty of soap and water. |
P351 | Rinse cautiously with water for several minutes. |
P352 | Wash with plenty of soap and water. |
P353 | Rinse skin with water/shower. |
P360 | Rinse immediately contaminated clothing and skin with plenty of water before removing clothes. |
P361 | Remove/Take off immediately all contaminated clothing. |
P362 | Take off contaminated clothing and wash before reuse. |
P363 | Wash contaminated clothing before reuse. |
P370 | In case of fire: |
P371 | In case of major fire and large quantities: |
P372 | Explosion risk in case of fire. |
P373 | DO NOT fight fire when fire reaches explosives. |
P374 | Fight fire with normal precautions from a reasonable distance. |
P376 | Stop leak if safe to do so. Oxidising gases (section 2.4) 1 |
P377 | Leaking gas fire: Do not extinguish, unless leak can be stopped safely. |
P378 | |
P380 | Evacuate area. |
P381 | Eliminate all ignition sources if safe to do so. |
P390 | Absorb spillage to prevent material damage. |
P391 | Collect spillage. Hazardous to the aquatic environment |
P301 + P310 | IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician. |
P301 + P312 | IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell. |
P301 + P330 + P331 | IF SWALLOWED: Rinse mouth. Do NOT induce vomiting. |
P302 + P334 | IF ON SKIN: Immerse in cool water/wrap in wet bandages. |
P302 + P350 | IF ON SKIN: Gently wash with plenty of soap and water. |
P303 + P361 + P353 | IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower. |
P304 + P312 | IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell. |
P304 + P340 | IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing. |
P304 + P341 | IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P305 + P351 + P338 | IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. |
P306 + P360 | IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes. |
P307 + P311 | IF exposed: call a POISON CENTER or doctor/physician. |
P308 + P313 | IF exposed or concerned: Get medical advice/attention. |
P309 + P311 | IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician. |
P332 + P313 | IF SKIN irritation occurs: Get medical advice/attention. |
P333 + P313 | IF SKIN irritation or rash occurs: Get medical advice/attention. |
P335 + P334 | Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages. |
P337 + P313 | IF eye irritation persists: Get medical advice/attention. |
P342 + P311 | IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician. |
P370 + P376 | In case of fire: Stop leak if safe to Do so. |
P370 + P378 | In case of fire: |
P370 + P380 | In case of fire: Evacuate area. |
P370 + P380 + P375 | In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion. |
P371 + P380 + P375 | In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion. |
Storage | |
Code | Phrase |
P401 | |
P402 | Store in a dry place. |
P403 | Store in a well-ventilated place. |
P404 | Store in a closed container. |
P405 | Store locked up. |
P406 | Store in corrosive resistant/ container with a resistant inner liner. |
P407 | Maintain air gap between stacks/pallets. |
P410 | Protect from sunlight. |
P411 | |
P412 | Do not expose to temperatures exceeding 50 oC/ 122 oF. |
P413 | |
P420 | Store away from other materials. |
P422 | |
P402 + P404 | Store in a dry place. Store in a closed container. |
P403 + P233 | Store in a well-ventilated place. Keep container tightly closed. |
P403 + P235 | Store in a well-ventilated place. Keep cool. |
P410 + P403 | Protect from sunlight. Store in a well-ventilated place. |
P410 + P412 | Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF. |
P411 + P235 | Keep cool. |
Disposal | |
Code | Phrase |
P501 | Dispose of contents/container to ... |
P502 | Refer to manufacturer/supplier for information on recovery/recycling |
Physical hazards | |
Code | Phrase |
H200 | Unstable explosive |
H201 | Explosive; mass explosion hazard |
H202 | Explosive; severe projection hazard |
H203 | Explosive; fire, blast or projection hazard |
H204 | Fire or projection hazard |
H205 | May mass explode in fire |
H220 | Extremely flammable gas |
H221 | Flammable gas |
H222 | Extremely flammable aerosol |
H223 | Flammable aerosol |
H224 | Extremely flammable liquid and vapour |
H225 | Highly flammable liquid and vapour |
H226 | Flammable liquid and vapour |
H227 | Combustible liquid |
H228 | Flammable solid |
H229 | Pressurized container: may burst if heated |
H230 | May react explosively even in the absence of air |
H231 | May react explosively even in the absence of air at elevated pressure and/or temperature |
H240 | Heating may cause an explosion |
H241 | Heating may cause a fire or explosion |
H242 | Heating may cause a fire |
H250 | Catches fire spontaneously if exposed to air |
H251 | Self-heating; may catch fire |
H252 | Self-heating in large quantities; may catch fire |
H260 | In contact with water releases flammable gases which may ignite spontaneously |
H261 | In contact with water releases flammable gas |
H270 | May cause or intensify fire; oxidizer |
H271 | May cause fire or explosion; strong oxidizer |
H272 | May intensify fire; oxidizer |
H280 | Contains gas under pressure; may explode if heated |
H281 | Contains refrigerated gas; may cause cryogenic burns or injury |
H290 | May be corrosive to metals |
Health hazards | |
Code | Phrase |
H300 | Fatal if swallowed |
H301 | Toxic if swallowed |
H302 | Harmful if swallowed |
H303 | May be harmful if swallowed |
H304 | May be fatal if swallowed and enters airways |
H305 | May be harmful if swallowed and enters airways |
H310 | Fatal in contact with skin |
H311 | Toxic in contact with skin |
H312 | Harmful in contact with skin |
H313 | May be harmful in contact with skin |
H314 | Causes severe skin burns and eye damage |
H315 | Causes skin irritation |
H316 | Causes mild skin irritation |
H317 | May cause an allergic skin reaction |
H318 | Causes serious eye damage |
H319 | Causes serious eye irritation |
H320 | Causes eye irritation |
H330 | Fatal if inhaled |
H331 | Toxic if inhaled |
H332 | Harmful if inhaled |
H333 | May be harmful if inhaled |
H334 | May cause allergy or asthma symptoms or breathing difficulties if inhaled |
H335 | May cause respiratory irritation |
H336 | May cause drowsiness or dizziness |
H340 | May cause genetic defects |
H341 | Suspected of causing genetic defects |
H350 | May cause cancer |
H351 | Suspected of causing cancer |
H360 | May damage fertility or the unborn child |
H361 | Suspected of damaging fertility or the unborn child |
H361d | Suspected of damaging the unborn child |
H362 | May cause harm to breast-fed children |
H370 | Causes damage to organs |
H371 | May cause damage to organs |
H372 | Causes damage to organs through prolonged or repeated exposure |
H373 | May cause damage to organs through prolonged or repeated exposure |
Environmental hazards | |
Code | Phrase |
H400 | Very toxic to aquatic life |
H401 | Toxic to aquatic life |
H402 | Harmful to aquatic life |
H410 | Very toxic to aquatic life with long-lasting effects |
H411 | Toxic to aquatic life with long-lasting effects |
H412 | Harmful to aquatic life with long-lasting effects |
H413 | May cause long-lasting harmful effects to aquatic life |
H420 | Harms public health and the environment by destroying ozone in the upper atmosphere |
Sorry,this product has been discontinued.
Home
* Country/Region
* Quantity Required :
* Cat. No.:
* CAS No :
* Product Name :
* Additional Information :